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Neurons are highly complex and polarised cells that must overcome a series
of logistic challenges to maintain homeostasis across their morphological
domains. A very clear example is the propagation of neurotrophic signalling
from distal axons, where target-released neurotrophins bind to their receptors
and initiate signalling, towards the cell body, where nuclear and cytosolic
responses are integrated. The mechanisms of propagation of neurotrophic sig-
nalling have been extensively studied and, eventually, the model of a ‘sig-
nalling endosome’, transporting activated receptors and associated complexes,
has emerged. Nevertheless, the exact nature of this organelle remains elusive.
In this Review, we examine the evidence for the retrograde transport of neu-
rotrophins and their receptors in endosomes, outline some of their diverse
physiological and pathological roles, and discuss the main interactors, mor-
phological features and trafficking destinations of a highly flexible endosomal
signalling organelle with multiple molecular signatures.
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Where trafficking meets signalling
How to propagate a retrograde signal
The complexity and high polarisation of neurons
impose a mighty challenge for the precise and timely
delivery of material to different subcellular compart-
ments, which is needed for differentiation and homeo-
static control. Proper function of the nervous system
relies on the ability of neurons to integrate events
occurring across their different domains to regulate
their metabolism, excitability, and morphology [1–3].
A very clear example of this challenge is how neu-
rotrophic factors secreted by target cells are sensed by
axon terminals, and how their signals are propagated
towards the cell body to have an impact on gene
expression, synapse formation, dendritic branching,
survival, or targeted cell death [4].
Neurotrophins constitute a family of homodimeric
ligands that includes nerve growth factor (NGF),
brain-derived neurotrophic factor (BDNF), neu-
rotrophin-3 (NT3), and neurotrophin-4/5 (NT4/5).
They bind two different types of receptors, tropomyo-
sin-related kinase receptors (Trk) and the p75 neu-
rotrophin receptor (p75NTR). Trk receptors bind
specific neurotrophins; TrkA binds preferentially
NGF, TrkB binds BDNF and NT-4/5, and TrkC
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binds NT-3. When activated, they promote cell sur-
vival, axonal growth, and dendritic branching through
their interaction with specific neurotrophins and down-
stream activation of signalling cascades, comprising
phosphoinositide 3-kinase (PI3K)-Akt pathway, mito-
gen-activated protein kinases (MAPKs) and phospholi-
pase C-gamma (PLCc) [5]. In contrast, p75NTR binds
all neurotrophins with similar affinity, as well as their
unprocessed forms called proneurotrophins, and other
ligands [6]. Due to its lack of intracellular catalytic
activity, p75NTR depends on ligand-induced recruit-
ment of adaptors and coreceptors to exert a wide
range of diverse functions, such as potentiating TrkA
prosurvival pathways, synergising with sortilin to
induce cell death, or interacting with NogoR to induce
growth cone collapse [7–9].
Propagation mechanisms of retrograde neurotrophic
signalling have been extensively studied. Rita Levi-
Montalcini observed that radiolabelled NGF accumu-
lates in sympathetic ganglia after subcutaneous or
systemic injection, suggesting that the ligand is actively
transported from the periphery to neuronal somata
[10]. In a follow-up study, Hendry and colleagues
demonstrated in 1974 that iodinated NGF injected
into the interior eye chamber is taken up by the sym-
pathetic terminals, retrogradely transported to the
superior cervical ganglion in a process requiring micro-
tubules, and accumulates in cell bodies for up to 16 h
[11].
The discovery that, after ligand-induced internalisa-
tion, TrkA and TrkB receptors are rapidly transported
from axon terminals to soma [12,13], together with the
evidence showing that receptors engage specific sig-
nalling pathways from postendocytic compartments
[14,15], enabled the formulation of the ‘signalling
endosome’ hypothesis, coined by the group of William
Mobley [16,17]. According to this model, internalised
receptors together with their cargos are transported in
specialised endosomes, where they are able to interact
with different signalling molecules to regulate local
events in axon and dendrites, as well as long distance
effects in the cell body, including gene expression [18].
In the last 20 years, extensive research using in vitro
compartmentalised cultures and in vivo models, high-
resolution fluorescence microscopy, electron micro-
scopy and biochemistry, has permitted the detailed
analysis of retrograde signalling carriers distribution,
composition, and function. Two methodological
approaches have particularly furthered our under-
standing of these organelles. The first is the use of
time-lapse fluorescence microscopy to follow endo-
somes, analyse their biogenesis, the frequency and
speed of retrograde transport, and how the latter is
affected under pathological conditions [19–23]. Second,
subcellular fractionation, as well as affinity purification
methods targeting retrograde signalling carriers, has
shed light on their molecular signatures, including the
machinery that regulate their transport, specific orga-
nelle markers, transported receptors, and associated
signalling complexes [24–27].
Axonal transport machinery and retrograde
signalling
The retrograde transport of neurotrophins and their
receptors relies on the polarised distribution of micro-
tubules in axons. Axonal microtubules are uniformly
oriented with their plus-end facing towards the distal
axon. Distal dendrites display a similar orientation of
microtubule, whereas a mixed distribution can be
found in proximal dendrites [28,29]. Molecular motor
complexes recognise the lattice of this organised micro-
tubule array and drive directional transport, with most
kinesins moving cargoes towards the microtubules
plus-end and cytoplasmic dynein towards the minus-
end [30]. Based on the directionality of their move-
ment, the retrograde axonal neurotrophic signalling
therefore depends on cytoplasmic dynein transport
[31]. The dynein complex is formed by six components,
each of them present as dimers: the dynein heavy
chain (DHC), the intermediate chains (DIC), the light
intermediate chains (DLIC), and three light chains
(DLC). The dynein complex interacts with the dyn-
actin complex, which is necessary for dynein activity
[32]. Signalling endosomes carrying activated TrkA
associate with the neuron-specific variant DIC-1B [33],
and upon NGF or BDNF stimulation, DIC is phos-
phorylated by ERK1/2, a kinase-activated downstream
to Trk receptors, promoting the recruitment of the
cytoplasmic dynein complex to signalling endosomes
[34]. Signalling endosomes also associate with the
DLC Tctex1, although it is presently unclear whether
this process is activity-dependent [35]. In cortical neu-
rons, TrkB-containing endosomes use the dynein adap-
tor Snapin, which interacts with DIC and recruits the
dynein complex. In a Snapin knockout model, the ret-
rograde transport of TrkB is reduced, negatively
affecting BDNF signalling in the soma [36]. However,
the finding that axonal transport of TrkB is not com-
pletely abolished in neurons lacking Snapin indicates
that multiple adaptors recruit cytoplasmic dynein on
signalling endosomes.
To trigger the neurotrophic retrograde signalling,
Trk receptors first need to reach the axonal tip. The
delivery of TrkB from the soma to the distal axon
depends on kinesin-1, which binds to a complex
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constituted by collapsin response mediator protein 2,
Slp1 and Rab27B, in cultured hippocampal neurons
[37]. Alternatively, TrkB can also associate in the
same cellular model to c-Jun NH2-terminal kinase-
interacting protein 3 (JIP3), which directly binds kine-
sin-1 light chain, and mediates the anterograde trans-
port of TrkB in axons, but not in dendrites [38]. In
sensory neurons, the anterograde transport of TrkA is
carried out in Rab3-positive carriers by the kinesin-3
family member, KIF1A. Dorsal root ganglia (DRGs)
from a Kif1a+/ mouse model exhibit progressive
TrkA-positive sensory neuron loss, and develop sen-
sory neuropathy [39].
The transport of signalling endosomes also
requires an intact actin cytoskeleton. For instance, in
motor neurons in culture, the trafficking of signalling
endosomes labelled with a nontoxic fragment of the
tetanus toxin (HCT), is impaired after treatment with
Latrunculin B, an inhibitor of actin polymerisation.
In agreement with this, the retrograde transport of
these endosomes relies on the coordination between
cytoplasmic dynein and myosin Va [40]. The afore-
mentioned study takes advantage of an interesting
feature of the tetanus toxin (TeNT); namely, that
TeNT and its binding fragment HCT are transported
in axonal neurotrophic signalling endosomes [22,41].
Therefore, fluorescent versions of these bacterial pro-
teins are excellent tools to monitor axonal transport
of neurotrophins and their receptors [42]. TeNT is
not the only virulence factor or pathogen trans-
ported in this way, in fact, the signalling endosome
pathway is a main portal for neurotrophic viruses
and virulent factors targeting the central nervous sys-
tem [43].
Axonal transport and signalling endosome dynamics
are coordinated by Rab GTPases, which are master
regulators of intracellular membrane trafficking. They
function as molecular switches, cycling between an
active, GTP-bound, and an inactive, GDP-bound
states. Since their intrinsic GTPase activity is very low,
the active state is promoted by guanine nucleotide
exchange factors (GEFs) and the inactive state is medi-
ated by GTPase-activating proteins (GAPs) [44]. Dur-
ing the Rab cycle, Rab GTPases change their cellular
distribution, with the GTP-bound state thought to
associate to the membrane of the target organelle,
whilst the GDP-bound state remains cytosolic,
although evidence for a GTP-independent membrane
recruitment is emerging [45]. A subset of Rab interac-
tors binds preferentially to the GTP-bound state, act-
ing as downstream effectors of the Rab activation
cascade. Interestingly, some of the Rab effectors are
GEFs or GAPs of other Rabs, enabling the interaction
between different organelles and the progression of
cargoes from one to another [46].
Upon internalisation, neurotrophin receptors are
sorted to the endocytic pathway, therefore Rab
GTPases regulating the endocytic network are pivotal
for neurotrophic signalling. Rab5 is a main determi-
nant of early endosome identity, regulating their motil-
ity and homotypic fusion, while Rab7 controls the
maturation of late endosomes, their trafficking, and
fusion to lysosomes, among other functions [47]. In
the endocytic pathway, Rab5 recruits Vps34, a lipid
kinase that generates phosphatidylinositol-3 phosphate
(PtdIns(3)P), and Rabaptin-5, which in turn stabilise
the Rab5 GEF Rabex-5, generating a Rab5-GTP posi-
tive feedback loop. Rabex-5 and PtdIns(3)P are
required for the association of Mon1, and the Mon1-
Ccz1 complex to early endosomes. This complex has
been shown to act as Rab7 GEF, and together with
the Rab5 effector homotypic fusion and sorting com-
plex (HOPS), recruits Rab7 to the endosomal mem-
brane. Additionally, Mon1 interrupts the Rab5
positive feedback loop, enabling the exchange of Rab5
for Rab7 [48]. This process is known as Rab conver-
sion and contributes to the mechanism by which early
endosomes mature into late endosomes [49]. Rab con-
version also exemplifies how Rab GTPases define the
identity of subcellular compartments [50]. Which Rab
GTPases, GEFs, GAPs, and effectors characterise the
retrograde signalling carriers is one of the key aspects
defining their identity and will be discussed below.
The subcellular localisation of neurotrophin recep-
tors is crucial for the proper regulation of their down-
stream signalling. In this regard, neurotrophic
signalling controls the trafficking of its own receptors.
An example of this can be found during migration of
cerebellar granule cell precursors (GCPs), which occurs
along a BDNF gradient. In response to this gradient,
activated TrkB receptors carried by signalling endo-
somes accumulate at the leading edge of GCPs, which
is oriented towards the BDNF source. TrkB phospho-
rylation induces the release of BDNF from GCPs, gen-
erating an autocrine loop and amplifying the BDNF
gradient [51]. It has also been shown that in cultured
hippocampal neurons stimulated with BDNF, acti-
vated TrkB receptors interact with the transmembrane
protein retrolinkin, driving endocytosis of phosphory-
lated TrkB (pTrkB) and sorting to early endosomes
positive for the Rab5 effector APPL1 [52]. Retrolinkin
also recruits endophilin A1 to these signalling endo-
somes, which allows the downstream activation of
ERK1/2 and boosts dendritic outgrowth [52]. Den-
dritic branching is also regulated by BDNF in hip-
pocampal neurons, where activated TrkB accumulates
3617FEBS Letters 592 (2018) 3615–3632 ª 2018 The Authors. FEBS Letters published by John Wiley & Sons Ltd on behalf of
Federation of European Biochemical Societies.
D. Villarroel-Campos et al. The signalling endosome’s disguises
in Rab11-positive recycling endosomes. BDNF-
triggered TrkB activation raises the levels of Rab11-GTP
in dendrites, increasing both the size and the number
of stationary recycling endosomes. As a consequence,
TrkB levels in dendrites are increased, sensitising neu-
ron to BDNF and promoting dendritic branching [53].
Neurotrophic signalling regulates multiple processes,
and neurotrophin receptors exhibit different destina-
tions. The maintenance of cellular homeostasis and sur-
vival rely on the ability of neurons to coordinate the
journey of these receptors in the endocytic pathway and
their sorting after reaching the cell body. In this review,
we will briefly present the different cellular roles of ret-
rograde neurotrophic signalling and some key examples
of pathological dysfunction in neurodegenerative dis-
eases. We will then discuss the identity of the signalling
endosome, its composition, and destinations.
Retrograde neurotrophic signalling in
physiology and pathology
Physiological roles
The regulation of neuronal survival was the first func-
tion originally described for neurotrophic factors, and
is intrinsically linked to their discovery [54]. During
their studies monitoring neuronal death during embry-
onic development in chick embryos, Viktor Ham-
burger and Rita Levi-Montalcini observed that after
removal of the wing bud, massive neuronal degenera-
tion takes place in the brachial ganglion innervating
the ipsilateral side, at the time when axonal projections
reach their targets. They concluded that ‘adequate con-
nections with the periphery are necessary for the main-
tenance of sensory neurons’ [55]. These set of
experiments gave rise to the neurotrophic factor the-
ory, which states that during development, neurons are
overgenerated, hence in order to survive, they compete
for target-derived trophic factors that are supplied in
limited availability [56]. Further experiments led to the
isolation of NGF as the factor-promoting survival and
maintenance of sympathetic neurons [57,58]. Knockout
mice models confirmed those observations, and
expanded the neurotrophic factor theory to other
members of the neurotrophic family. For instance,
NGF and TrkA null mice show an extensive reduction
in total neuron number in DRGs and trigeminal gan-
glion after birth, with almost complete absence of sym-
pathetic ganglia after 10 days [59,60]. BDNF and
TrkB knockout models exhibit overt neuronal loss in
the vestibular ganglion, as well as moderate but signifi-
cant neuronal death in DRGs [61,62]. Finally, NT3
null models revealed a marked reduction in
proprioceptive DRG neurons, with a concomitant
impairment of muscle spindle development [63], a role
that is independent of NT3 signalling through TrkC
[64]. At the molecular level, internalisation and retro-
grade trafficking of the NGF/TrkA complex are
required for the promotion of neuronal survival [65].
Distal NGF stimulation of DRGs or sympathetic neu-
rons in compartmented cultures triggers the phospho-
rylation and activation of the transcription factor
cAMP response element-binding protein (CREB) in
the cell body, [66,67]. Phosphorylated CREB induces
the expression of the antiapoptotic protein Bcl-2, and
in this way promotes neuronal survival [68]. NGF/
TrkA retrograde signalling, acting through ERK5, also
promotes the expression and activation of the tran-
scription factor MEF2D, which in turn drives the
expression of Bcl-w, another member of the bcl-2 fam-
ily with antiapoptotic activity [69,70]. Interestingly,
upon target innervation, NGF enhances the expression
of TrkA in sympathetic neurons, establishing a posi-
tive feedback loop that enhances prosurvival sig-
nalling, and at the same time releasing BDNF and
NT4, which act as paracrine apoptotic cues that
induce death of neighbouring cells through p75NTR
[71].
In addition to promoting neuronal survival, the retro-
grade neurotrophic signalling also regulates other cellu-
lar processes, including the control of axonal growth.
NGF triggers axon elongation when applied to distal
axons of sympathetic neurons, whereas NGF with-
drawal induces axon collapse even if it is kept in the
somatic compartment [72]. In knockout models, the
analysis of the effect of neurotrophins on axonal growth
requires the ability to discern phenotypic changes inde-
pendently of their survival roles. This daunting task has
been achieved by studying NGF- and TrkA-deficient
mice in a Bax/ background, in which sympathetic
and DRG neurons overcome cell death in spite of the
absence of NGF/TrkA signalling. In these models, some
sympathetic innervations are completely absent, while
others are partially spared, or not changed at all; this
marked heterogeneity depends on the target organs and
their different requirements for NGF-dependent sympa-
thetic innervation [73]. Accordingly, the superficial cuta-
neous innervation of DRG neurons is absent; however,
the projections targeting the dorsal horn of the spinal
cord are preserved [74]. Specific transcription factors
acting downstream of NGF regulate axon growth inde-
pendent of survival effects; this is the case of nuclear
factor of activated T cells, serum response factor, and
early growth response 3 [75–77].
In addition to retrograde signalling, NGF-dependent
axon elongation also requires local signalling, such as
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the activation of PI3K at the growth cone, which inac-
tivates glycogen synthase kinase 3 beta (GSK3ß) and
regulates cytoskeletal dynamics through the micro-
tubule plus-end binding protein adenomatous polypo-
sis coli (APC) [78]. Interestingly, both NGF and NT3
promote axon growth in sympathetic neurons through
TrkA; however, the effect of NT3 is restricted to prox-
imal elongation across the vasculature, whilst distal
elongation and target innervations depend on NGF.
This spatially controlled regulation is determined by
the distinct TrkA signalling triggered by NT3 and
NGF, since NT3 is unable to induce TrkA internalisa-
tion and signalling from endosomal compartments
[79]. Conversely, TrkA activation by NGF induces the
calcineurin-dependent dephosphorylation of dynamin
1, which in turn mediates TrkA endocytosis, a crucial
step necessary for the induction of axon growth [80].
Dendritic growth and synapse maintenance are also
regulated by retrograde neurotrophin signalling. Quan-
titative morphometric analysis has shown that superior
cervical ganglion neurons innervating larger targets
elaborate more complex dendritic arborisations [81],
and after axonal crush, their dendrites accumulate
large varicosities in the distal segment, altering their
morphology [82]. In addition, in vivo NGF stimulation
in mice increases sympathetic neurons dendritic length,
branching, and number of primary dendrites [83].
Nerve growth factor-TrkA signalling also modulates
synapse formation and maintenance. Indeed, a sub-
population of NGF-TrkA signalling endosomes origi-
nated in distal axons of postganglionic neurons, are
retrogradely transported into dendrites, where TrkA-
dependent MAPK activity induces postsynaptic density
clustering. Activation of TrkA in axonal signalling
endosomes is also essential for the maintenance of
synapses between pre- and postganglionic neurons,
both in vitro and in vivo [84,85]. Taken together, the
control of target innervation, and synapse formation
and maintenance, exemplify how retrograde neu-
rotrophic signalling regulates network formation in the
nervous system, a topic reviewed elsewhere [86,87].
An additional role of neurotrophic signalling is the
regulation of phenotypic specification of neurons. For
example, in double Bax//TrkA/ mice, peptidergic
nociceptors that failed to innervate distal targets do
not express markers of their lineage, such as calcitonin
gene-related peptide and substance P [74]. Although
the fate of this neuronal population is unclear, the
absence of markers suggests a role of NGF on its phe-
notypic differentiation. NGF also regulates the pheno-
typic differentiation of nonpeptidergic nociceptors. In
this cell population, Ret, the coreceptor for glial-
derived neurotrophic factor (GDNF), is expressed
upon NGF stimulation. Ret induces the expression of
the GDNF coreceptors GFRa1 and GFRa2, as well
as other genes characteristic of the nonpeptidergic lin-
eage. In the same neuronal subtype, NGF triggers the
ERK1/2 pathway downstream to TrkA, and induces
the expression of CBFb, a cofactor of the Runx family
of transcription factors, which upon binding to Runx1,
promotes the nonpeptidergic nociceptor fate [88,89].
An example from the central nervous system is the
phenotypic differentiation of basal forebrain choliner-
gic neurons. When their projections innervating the
hippocampus are transected, thus inhibiting the target-
derived supply of NGF, these neurons stop the expres-
sion of cholinergic markers, such as choline acetyl
transferase, as well as the neurotrophin receptors
p75NTR and TrkA. Although originally considered as
evidence of cholinergic degeneration, the number of
neurons remains unaltered and there is no evidence for
neuronal apoptosis, suggesting that in this model,
NGF is required for maintenance of phenotypic differ-
entiation, but not for neuronal survival [90].
Strong evidence linking neurotrophin signalling to
local protein synthesis and RNA transport is starting to
emerge. For instance, Impa1 mRNA is transported and
translated in the axon in a NGF-dependent manner, in
sympathetic neurons grown in compartmentalised cul-
tures. Impa1 is one of the most abundant axonal tran-
scripts, and its product (myoinositol monophosphatase-
1) is a key enzyme in the inositol pathway, which con-
trols the cellular levels of phosphatidilinositol [91].
NGF also promotes the transport of lamin B2 and Bcl-
w mRNAs (Lmnb2 and Bcl2 l2) towards the axon. Both
mRNAs are cotransported in RNA granules assembled
by the RNA-binding protein SFPQ. In this pathway,
SFPQ acts downstream to NGF/TrkA, and its role is
necessary for neurotrophin-dependent axon viability
[92]. However, it is unclear whether these functions
require the retrograde transport of signalling endo-
somes, or if they rely on local signalling. On the other
hand, the NGF-triggered delivery of b-actin mRNA to
the axon in cultured adult DRG neurons is dependent
on retrograde signalling. This process requires the PI3K
and MAPK pathways, and is impaired by the dynein
inhibitor EHNA [93]. Further studies are, however,
needed to characterise the role of the retrograde neu-
rotrophic signalling on mRNA transport and local
translation, both in axons and dendrites.
Roles in pathology
Neurotrophins and their receptors have been involved
in the pathogenesis of a variety of diseases, including
psoriasis [94], allergies [95], and cancer [96,97].
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However, given their crucial role in neuronal home-
ostasis, deregulation or impairment of axonal trans-
port of neurotrophin signalling endosomes is a
common feature in many neurodegenerative condi-
tions. Here, we present some examples highlighting the
deficits in retrograde signalling in pathology, whilst a
comprehensive coverage of this topic can be found
elsewhere [20,98].
Alzheimer’s disease is a progressive neurodegenera-
tive disorder characterised by memory loss and cogni-
tive decline. The molecular hallmarks of this
pathology include accumulation of extracellular pla-
ques containing amyloid beta (Ab) oligomers, and
intracellular neurofibrillary tangles [99]. Ab oligomers
reduce the transport of endosomes carrying BDNF-
GFP, through a mechanism replicated by the inhibi-
tion of the deubiquitinating enzyme UCH-L1 [100]. In
addition, increased expression of amyloid precursor
protein or its proteolytic fragment C99 upregulates
Rab5 activity, inducing enlargement of Rab5-positive
endosomes and reduced retrograde axonal transport of
NGF in basal forebrain cholinergic neurons, which
leads to cholinergic neuronal degeneration [101,102].
In this regard, clinical trials involving NGF gene deliv-
ery have been carried out, showing evidence of a
trophic response (i.e. cholinergic axonal sprouting)
that was detectable even 10 years after treatment [103].
Huntington’s disease is caused by a polyglutamine
(polyQ) expansion in huntingtin (Htt), and manifests
with progressive cognitive, motor, and behavioural
impairments that eventually become fatal [104].
Although the multifaceted functions of wild-type Htt
are still matter of debate, it has been shown to form a
complex with huntingtin-associated protein 1 and the
dynactin subunit p150Glued [105]. This complex is
required for the retrograde transport of BDNF, a pro-
cess inhibited by polyQ-Htt, which leads to loss of
neurotropic support and consequent neuronal toxicity
[106]. In agreement with this model, expression of
polyQ-Htt reduces the retrograde transport of TrkB-
BDNF complexes in dendrites of striatal neurons
[107]. In addition, reduction of wild-type Htt expres-
sion inhibits the retrograde transport of Rab7-positive
vesicles in Drosophila larval axons [108].
Amyotrophic lateral sclerosis (ALS) is a progressive
neurodegenerative disease affecting upper and lower
motor neurons, which leads to muscle denervation and
wasting, paralysis and death [109]. The pathomecha-
nisms at the basis of this disease are diverse; however,
axonal transport defects are considered among the ear-
liest disease phenotypes [21]. One of the most charac-
terised models of familial ALS is a mouse strain
expressing a mutant form (G93A) of human
superoxide dismutase 1 (SOD1) [110]. Cultured pri-
mary motor neurons derived from SOD1G93A mice
present altered retrograde transport of signalling endo-
somes with fewer carriers, higher number of pauses,
and oscillatory movements [111]. This was confirmed
in vivo, starting at presymptomatic stages of disease
[19,112]. Interestingly, the defects in retrograde axonal
transport in ALS precede the alterations reported in
anterograde transport [113,114] as well as other cellu-
lar pathological phenotypes, suggesting that alterations
in retrograde transport may be a direct cause of this
pathology, rather than a consequence. Interestingly, a
form of familial early-onset ALS is caused by muta-
tions in the Rab5 GEF Alsin [115]. Alsin loss of func-
tion deregulates the trafficking along the
endolysosomal pathway in cultured motor neurons
[116], and interferes with the transport of TrkB and
insulin-like growth factor 1 receptor in cortical and
cerebellar granule neurons [117].
Charcot-Marie-Tooth disease (CMT) is the most
common inherited peripheral neuropathy, affecting
both sensory and motor nerves [118]. CMT type 2B is
caused by mutations in Rab7 that lead to a decreased
nucleotide affinity and unregulated nucleotide
exchange, without affecting its hydrolytic activity.
These Rab7 mutants resemble the constitutively active
Rab7Q67L; they exhibit enhanced interaction with a
subset of Rab7 effectors, and are abnormally retained
on target membranes [27,119]. CMT-related Rab7
mutants affect the directionality of movement of
Rab7-positive endosomes, as well as the transport of
carriers containing TrkA in NGF-stimulated DRG
cultures [120]. The dynamics of Rab7-positive endo-
somes is also altered in Drosophila and zebrafish
CMT2B disease models, where a reduction of the
pausing time has been reported for the Rab7 L129F,
N161T, and V162M mutants [121,122]. The possibility
that the impairment in axonal transport of NGF con-
stitutes a more general pathological mechanism for
other CMT subtypes has been recently explored in a
study showing a reduction of velocity and an increase
in pausing of retrograde NGF in a GarsP234KY/+
model of CMT2D [123].
A new organelle or a master of
disguise?
Formation and molecular signatures
From a biogenesis perspective, the retrograde sig-
nalling carriers are unequivocally endosomes: they
originate from the plasma membrane when neu-
rotrophins bind their receptors and trigger their
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endocytosis (Fig. 1A,A’]). Internalisation of receptors
is crucial not only for long distance propagation of
neurotrophic effects, but also for engaging intracellular
interactors enabling the activation of distinct signalling
pathways [15,124]. It is critical for local effects relying
on the accumulation of signalling molecules at specific
locations, as in the case of synaptic assembly sites,
branching points on neurites and the leading edge of a
migrating precursor [51,53,84,85,125].
Specific mechanisms of internalisation have proved
to be particularly important for generating intracellular
compartments with distinct signalling capabilities.
Using PC12 cells and DRG neurons, the group of Wil-
liam Mobley observed that upon NGF stimulation,
recruitment of clathrin to the plasma membrane was
increased, and TrkA receptors were rapidly endocy-
tosed and sorted to small peripheral organelles together
with NGF. Isolation of these endocytic vesicles showed
that they were enriched in phosphorylated receptors
together with clathrin heavy chain and its AP2 adaptor.
Different signalling molecules, including PI3K, PLCc
and ERK1/2, were also present in the same samples
[26]. However, Halegoua and colleagues subsequently
showed that clathrin-dependent endocytosis accounted
for only a fraction of internalised receptors in PC12
cells and DRGs, whilst a larger proportion was gener-
ated from macropinocytosis. They showed that sorting
of TrkA to signalling carriers depends on the Rho-
GTPase Rac and the macropinocytic adaptor Pincher.
These markers characterise a particular type of posten-
docytic organelle that, in contrast to signalling endo-
somes containing EGF receptors, was protected from
lysosomal degradation [126–128]. Interestingly, the
mechanism of internalisation varies depending on the
nature of the receptor, type of neuron, and ligand con-
centration. In this regard, Deinhardt and colleagues
have shown that in primary motor neurons NGF stim-
ulates the internalisation of p75NTR and its targeting to
the fast retrograde transport route by a mechanism ini-
tiated by the recruitment of p75NTR to clathrin-coated
invaginations, which relies on dynamin, but not AP2 or
AP180 adaptors [129].
After endocytosis, receptors are sorted to early
endosomes characterised by the presence of the
GTPase Rab5 (Fig. 1B,B’). Independent lines of evi-
dence suggest that Rab5-positive early endosomes are
the most likely source of retrograde signalling endo-
somes. Mobley and coworkers have extensively charac-
terised the ability of TrkA receptors to recruit specific
signalling molecules to early endosomes, which regu-
late cellular responses, such as neurite outgrowth, in
PC12 cells and DRG neurons [130,131]. They used
isolated sciatic nerve to show that, after several hours
of exposing the distal part of the nerve to NGF, sig-
nalling molecules including Rap1, PI3K, phosphory-
lated ERK1/2 and p38 were enriched in proximal
sections of the axon, together with p75NTR, phospho-
rylated-TrkA receptors and the early endosome mark-
ers Rab5 and EEA1 [25]. In addition, quantum
dots-labelled NGF internalised at DRG axon was
found in organelles positive for TrkA, phosphorylated
ERK1/2 and Rab5b [132].
The protein APPL1 is a Rab5 effector that has been
shown to regulate the sorting of a subpopulation of
early endosomes lacking EEA1 [133,134]. The group
of David Kaplan has shown that TrkA interacts with
APPL1, suggesting that a specific pool of early endo-
somes can function as signalling endosomes. TrkA,
APPL1, and GIPC1, a scaffolding protein that pro-
motes trafficking of APPL1 vesicles to early endo-
somes, were found in endosomal fractions, particularly
in axons of superior cervical ganglia neurons [135].
Notwithstanding the important role of early endo-
somes in the biogenesis and sorting of neurotrophin
receptor-containing carriers to the retrograde transport
route, Deinhardt et al. found that, in spinal cord
motor neurons, these organelles are characterised by
the presence of Rab7 (Fig. 1C). By using HCT to label
retrogradely transported endosomes, our laboratory
has been able to describe a trafficking route shared by
NGF, BDNF, p75NTR, and TrkB [41,129]. Upon cla-
thrin-dependent endocytosis, these cargoes are sorted
sequentially first to a Rab5-positive organelle that
shows oscillatory movement in axons, and then to a
Rab7-positive compartment undergoing fast retrograde
transport. In motor neurons, the initial sorting to an
early endosome is a required step to reach fast retro-
grade axonal carriers, as was demonstrated by using
dominant-negative mutants of Rab5. Moreover, the
axonal trafficking of Rab5 and Rab7 was shown to be
similar in DRG neurons [41].
Importantly, the presence of Rab7 does not appear
to target these organelles to degradation. During mat-
uration from late endosomes to lysosomes, the vAT-
Pase drives the acidification of the endosomal lumen,
providing the optimal environment for full cathepsin
activity and promoting the dissociation of ligands from
their receptors. The surprising finding that the vAT-
Pase is largely excluded from this compartment sug-
gests that these organelles do not belong to the
degradative pathway [136]. Interestingly, similar Rab7-
positive retrograde organelles are involved in the trans-
port of the P2X3 receptor in both motor and DRG
neurons [137].
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It is not clear whether Rab5-positive axonal orga-
nelles have different degrees of mobility in other neu-
ronal types. In hippocampal neurons, for example, it
has been shown that a substantial amount of Rab5 is
retrogradely transported, although its transport is not
very progressive [138]. However, when Zhou and col-
leagues followed fluorescent TrkB in the axon of corti-
cal neurons, most of the receptor was in Rab7-positive
organelles and relied on Snapin to interact with DIC,
thus engaging in retrograde axonal movement [36].
Moreover, when HCT-containing endosomes were
purified from mouse embryonic stem cell-derived
motor neurons using paramagnetic iron beads at dif-
ferent time points after endocytosis, the amount of
Rab5 associated to signalling endosomes progressively
decreased, whilst Rab7 increased about 50% from 10
to 60 min upon internalisation, which is consistent
with a sequential transit of the cargoes through
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Fig. 1. Retrograde neurotrophic signalling organelles and their main
destinations after arrival to the cell body. Different types of
signalling endosomes and their cellular destinations have been
displayed on the top of a camera lucida trace of a mouse primary
motor neuron in culture. The type of carriers and their sequential
trafficking steps emerge from evidence collected using diverse
experimental models, such as sensory, sympathetic, and motor
neurons. Whether they are all present in every neuronal subtype is
currently unknown. After being released by the target tissue, NGF
and BDNF bind to TrkA (A) and TrkB (A’) respectively, triggering
their phosphorylation and internalisation. TrkA-NGF (B) and TrkB-
BDNF (B’) complexes enter the endocytic pathway and reach the
early endosome, an organelle characterised by the presence of
Rab5. Retrograde transport of Rab5-positive carriers of TrkA-NGF
complex has been shown (thick arrow in B). Activated receptors
are then sorted into a late endosome compartment (C),
characterised by the presence of Rab7. This compartment can
undergo retrograde axonal transport towards the soma, or progress
along the endolysosomal route maturing into a multivesicular body
(MBV; D), which contains both Rab7 and CD63. MVBs can also
transport both receptor-ligand complexes to the cell soma. In
addition, autophagosomes have also been reported as retrograde
carriers for TrkB-BDNF (E). We have not included the origin of the
autophagosome in the axonal tip, since it is still a matter of debate.
After signalling endosomes reach the soma, there are sorted into a
variety of destinations. Several lines of evidence indicate that
neurotrophin receptors are delivered to somatic MVBs (F). TrkB-
BDNF in MVBs or single-membrane vesicles can be either
delivered to the plasma membrane or targeted to lysosomes for
degradation (G). A subpopulation of TrkA-NGF positive cargoes has
been shown to be transported into dendrites (H), where it
regulates synapse formation and maintenance. TrkA-NGF
complexes can also be recycled to the soma plasma membrane,
where they might activate na€ıve TrkA receptors (I) and induce their
recruitment to the anterograde axonal transport route in Rab11-
positive organelles (J). The activity of the endoplasmic reticulum-
resident phosphatase PTP1B is required to ensure that no activated
TrkA is sorted into axons. In parallel, a pool of newly synthesised
TrkA receptor is anterogradely transported in secretory vesicles
characterised by the presence of Rab27, CRMP2 and Slp1 (K).
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Rab5- and Rab7-positive compartments [24]. Since the
maturation of early endosomes to late endosomes
depends on the switch between Rab5 and Rab7 [49],
these apparently controversial observations may be
explained by the presence of a maturation gradient
along the axon, which depends on the neuronal type
and signalling context. In the work of Debaisieux and
colleagues, other Rabs were also found associated to
the purified retrograde carriers, suggesting that sub-
populations of Rab7- and Rab5-positive organelles
bearing specific small Rab GTPases may constitute
alternative pathways with distinct function(s) [24].
Consistent with this hypothesis, it has been reported
that the GTPase Rab11, generally associated to recy-
cling cargoes directed to the plasma membrane, is also
cotransported in TrkA-containing retrograde carriers
in sympathetic neurons [139,140].
An alternative hypothesis about the nature of the
retrograde signalling carriers is that they are multi-
vesicular bodies (MVBs; reviewed in [141]). These mul-
tiple-membrane organelles (Fig. 1D) belong to the
endolysosomal system [142] and have been shown to
act as specialised transport organelles as well as a
main source of exosomal vesicles [143]. The possibility
that MVBs may serve as retrograde carriers of acti-
vated neurotrophin receptors has been explored for
almost four decades and it is based on the notion that
specific cytoplasmic microenvironments are preserved
in the lumen of the MVB. This would allow a snap-
shot of the signalling molecules present at the axon
terminal at any particular time to be captured, trans-
ported, and made available in the soma [141]. Recent
evidence has strengthened the putative role of MVBs
in targeting neurotrophin receptors to particular desti-
nations. Consistent with the work showing that
Pincher-mediated internalised TrkB was sorted to
MVBs in the soma of superior cervical ganglia neurons
[126], the Bronfman group found that a pool of inter-
nalised p75NTR is sorted to a compartment positive for
CD63, a marker of MVBs, for its release in exosomes
[144]. Recently, Ginty’s group reported the first evi-
dence using live-cell imaging that CD63 and TrkA are
cotransported in retrograde carriers in the axon of
sympathetic superior cervical ganglion neurons. Inter-
estingly, the majority of axonal Rab5-positive orga-
nelles exhibited short-range bidirectional movement or
were immobile, whereas Rab7-organelles were most
frequently retrograde. These organelles were positive
for Lamp1, CD63, and RILP, and contained not only
phosphorylated TrkA, but also other signalling mole-
cules, including phosphorylated PLCc. This group pro-
posed that, after an initial sorting of the receptors to
early endosomes in axon terminals, these transport
organelles mature to MVBs that require Rab7 and its
effectors, such as RILP, to engage retrograde trans-
port. Some of the receptors would be exposed to the
cytoplasm on the limiting membrane, helping to define
the destination of these carriers, whereas the majority
of receptors would be protected in the intraluminal
vesicles. At their arrival in the cell body, MVBs would
disassemble, originating single-membrane vesicles with
signalling potential [145]. However, it is unlikely that
RILP is the only downstream effector of Rab7 respon-
sible for the coordination of retrograde transport,
since a dominant-negative mutant of RILP fails to
alter the dynamics of HCT-positive retrograde carriers
in spinal cord motor neurons (G. Schiavo, unpublished
results).
Other groups have suggested that a closely related
organelle, the autophagosome, is the main retrograde
carrier (Fig. 1E). Similarly to the MVBs, autophago-
somes are multimembrane organelles involved in the
degradation of a variety of organelles and cytoplasm
[146]. However, autophagosomes are generated by a
distinct mechanism involving the elongation of a
nucleating membrane to isolate a portion of cytoplasm
or a specific organelle. A constitutive, nondegradative
role has been suggested for autophagosomes by Erika
Holzbaur and her group, who showed that in hip-
pocampal neurons the generation of autophagosomes
occurs most frequently at axon terminals, and it is
independent of nutrient deprivation. These distally
generated autophagosomes undergo retrograde trans-
port and are not acidified until they reach the proxim-
ity of the cell body [147]. A distinctive marker of this
compartment is the protein LC3b, which participates
in the elongation of the nascent phagophore. Recent
work from the team of Volker Haucke using cortical
and hippocampal neurons has shown that AP2l inter-
acts with LC3b and regulates the retrograde transport
and maturation of autophagosomes via a mechanism
independent of its established role as a clathrin adap-
tor. pTrkB is found in AP2l- and LC3b-positive orga-
nelles and a knockout mouse of AP2l exhibited a
decrease in both the retrograde transport of TrkB and
dendritic complexity [148].
These partially conflicting observations point to an
intrinsic diversity in the molecular nature of retrograde
signalling carriers, whose relative abundance may be
finely regulated depending on the neuronal type, devel-
opmental stage or signalling, and activity context.
Complexity of membranes
An important morphological feature to help us to dis-
tinguish whether the retrograde signalling carriers are
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endosomes, autophagosomes or MVBs is their single-
or multiple-membrane nature. Early studies on the
generation of signalling endosomes in PC12 cells
showed that after Pincher-mediated macroendocytosis,
TrkA receptors were rapidly associated to MVBs [128].
Interestingly, when subcellular fractionation was used
to isolate NGF-containing postendocytic organelles in
PC12 cells, TrkA and p75NTR were found in different
populations of endosomal vesicles, translucent and
electron dense, respectively. However, a small propor-
tion of both receptors was also in MVBs [149]. More
recently, it has shown that 120 min after NGF-induced
internalisation, around 40% of p75NTR is localised to
MVBs, from which it can be released via an exosome-
mediated pathway [144].
Quantitative electron microscopy has played a key
role to unravel the pleiotropic nature of retrograde sig-
nalling endosomes in neurons. The group of Campenot
took advantage of a compartmentalised culture of
sympathetic neurons to show that 125I-NGF inter-
nalised in axons for 8–10 h was found in a variety of
compartments, including smooth ER, small translucent
vesicles, mitochondria, lysosomes, and MVBs [72,150].
The majority of the signal (37%) was associated to
lysosomes, which accounted for 10% of the fractional
area of the cell. Interestingly, MVBs were the most
densely labelled organelles, concentrating a 6.7% of
signal in just 0.4% of the area of the cell [150]. Consis-
tently, when the group of von Bartheld studied the ret-
rograde transport of BDNF in motor hypoglossal
neurons in vivo, they found that a large proportion of
the BDNF was arriving to the soma and dendrites in
MVBs [151]. Crucially, when they examined axonal
MVBs, they realised that organelles with multiple
membranes were devoid of radiolabelled neurotrophic
factors. In fact, most of the autoradiographic signal
detected in axonal samples had no direct apposition
nor spatial relationship with any observable organelles,
suggesting that neurotrophins were associated to small
vesicles that were masked by the autoradiographic pre-
cipitate. This observation was confirmed by using
quantum dot-conjugated BDNF [152].
Evidence showing that multiple-membrane orga-
nelles are a common destination for retrogradely trans-
ported neurotrophic factors in the soma and dendrites
appears to be consistent between cell lines and neu-
ronal types, including superior cervical ganglia and
hippocampal neurons [126–128] and embryonic stem
cells-derived motor neurons [153]. Whether the sig-
nalling complexes are transported in multiple-mem-
brane organelles along the axon, however, is less clear
from ultrastructural studies. Whereas the cited work of
Altick and colleagues dismissed MVBs as retrograde
carriers of neurotrophic factors [152], other authors
have suggested a clear role for them. For example, the
Meunier’s team has used cholera toxin B subunit
(CTB) in hippocampal neurons to label neurotrophic
factor-transporting organelles after axonal stimulation
with BDNF in microfluidic devices, and found CTB-
positive multiple-membrane organelle aligned with
other single-membrane vesicles in the axon [154].
Working with a different in vivo model, the group of
Hendry has proposed that MVBs are the main carriers
of retrograde NGF and its receptors in sympathetic
neurons [155].
Altogether, these findings suggest that neurotrophic
signalling complexes are transported along the axon in
organelles of different membrane complexity depend-
ing on the type of neuron, the nature of the neu-
rotrophin and its concentration. An interesting
possibility is that there is a gradual assembling of
endocytic vesicles into multiple-membrane organelles
as they move from the axon ending towards the cell
body. Supporting this hypothesis, a recent study from
Ye and colleagues has shown using that TrkA recep-
tors appear to be mainly in single-membrane vesicles
soon after internalisation in axonal tips of sympathetic
neurons, whilst they are found predominantly in
MVBs upon arrival to the proximal axon and cell
body [145]. Interestingly, the study of Altick in motor
neurons also identified axonal MVBs as highly
dynamic organelles and showed an example of vesicu-
lar fusion/fission in an axonal MVB [152].
Alternatively, based on the observation that MVBs
contain a large proportion of retrogradely transported
NGF accumulating in the soma [150], it can be
hypothesised that MVBs are not transporting orga-
nelles, but are the end destination where signalling
endosomes are targeted either to terminate the signal
or to release the receptors in the extracellular medium
via exosomes. Whether the formation of multiple-
membrane structures occurs in the axon of a particular
subpopulation of neurons or it is restricted to the cell
body, constitutes an important open question to be
addressed to clarify the nature of these axonal retro-
grade carriers and their dynamics.
Multiple destinations
What initially emerged as an answer for the problem
of the propagation of neurotrophic signalling from the
axon terminal to the soma is now becoming a more
sophisticated matter: the spatiotemporal regulation of
neurotrophic signalling in different domains of a living
neuron at a particular stage of differentiation and
under a certain physiological context.
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The prevalent destination of the neurotrophic signal
at any given time is probably the axon terminal. In
sympathetic neurons, it is estimated that less than
10% of internalised TrkA is targeted to the retrograde
transport route [156,157], while the reminder pool
recycles back to the terminal surface [158]. Concentra-
tion of ligand and receptor at the axon terminal has
been shown to be crucial to increase the sensitivity to
neurotrophins and promote axon growth, either by
local recycling of receptors or the recruitment of
anterogradely transported TrkA [139]. Whether or not
this is also true for p75NTR, it is currently not clear.
Nevertheless, it has been recently shown that after
treatment of sympathetic neurons with NGF, TrkA
receptors acting through the PI3K signalling pathway
mediate the Arf6-dependent fusion of intracellular
vesicles containing p75NTR to the plasma membrane,
rapidly increasing its levels at the cell surface, and
enhancing the sensitivity of neurons to NGF [159].
Retrogradely transported receptors that arrive to the
soma have been proven to drive gene expression, sur-
vival, dendritic plasticity, and synaptic maintenance
[36,70,84,160]. Many retrograde carriers containing
activated receptors are going to persistently signal
from late endosomes or other organelles until they fuse
to lysosomes, as shown in Fig. 1F. Nevertheless, some
of the functions in dendrites require the integrated
control of local and global signalling, a matter that
has been recently addressed by the Ginty’s group by
showing that in sympathetic neurons, a pool of retro-
gradely transported signalling endosomes were found
in dendrites (Fig. 1G) and in close proximity to
synapses [84]. Importantly, the majority of these orga-
nelles (~ 80%) remained mobile, whilst the soma-
bound endosomes are less dynamic, suggesting that
these organelles are different [84]. Recent work from
the group of Bettina Winckler explored the hetero-
geneity of retrograde signalling endosomes after their
arrival to the cell body. These authors showed that,
both in cultured neurons and in vivo, TrkA receptors
labelled at the distal axon are found in somatic orga-
nelles that were positive for a variety of endosomal
markers, including Rab7, Rab11, and EEA1. At
molecular level, they found that a large proportion of
the retrogradely transported TrkA in dendrites was
targeted to the cell surface either in the soma or den-
drites, prior to being sorted to different populations of
endosomes [140]. This novel sorting mechanism may
regulate the different outputs of activated receptors,
leading to dendrite-to-nucleus signalling [161] or local
actions (e.g. dendrite branching [125]).
Finally, it is also possible that receptors that have
been transported from the axonal tip to the soma are
targeted to anterograde transport [162]. It had been
previously shown that neurotrophic signalling origi-
nated from distal axons can promote anterograde
Trans-cytosis of TrkA and TrkB receptors from the cell
body, increasing sensitivity to ligand at the axon termi-
nal [139,163]. Recent work from the group of Rejji
Kuruvilla showed that in sympathetic neurons, a popu-
lation of retrogradely transported TrkA is inserted on
the plasma membrane at the soma (Fig. 1H), where
they can promote phosphorylation and endocytosis of
resident receptors. Once internalised, TrkA receptors
are dephosphorylated by the PTP1B phosphatase
before being transported anterogradely to the axon ter-
minal (Fig. 1I), suggesting a mechanism that allows
retention of the phosphorylated pool of receptors in
the somato-dendritic compartment, where they can
engage persistent signalling, whereas only inactive
receptors are sent back to the axon to regulate distal
neurotrophin sensitivity. Importantly, conditional dele-
tion of PTP1B in NGF+/ mice reduced axonal TrkA
levels, neuron survival and target innervation, empha-
sising the relevance of this mechanism in vivo, espe-
cially under limited availability of NGF [162].
Given the diversity of destinations, and the cellular
and functional outputs of retrograde signalling carri-
ers, an important unaddressed question is whether the
molecular signatures acquired during the biogenesis of
these organelles determine their final destination, or
whether the diversification of these carriers occurs at
their arrival in the cell body as a function of distinct
signalling contexts.
Concluding remarks: diversity matters
It is clear from the evidence herein presented that a
variety of axonal retrograde signalling carriers, which
differ in their molecular composition, are found in
neurons. They are also diverse in terms of biogenesis
and membrane complexity – some of them have been
characterised as conventional endosomes, whilst others
have been described as MVBs or autophagosomes.
These diverse observations can be explained at least
in part by differences in experimental models, for
example, the combination of receptors expressed by
different neuronal types, and the specific neurotrophic
factor under investigation. Results may be obtained
from the same cellular type but at different stages of
neuronal maturation, or focussing on different areas
of axon and dendrites. In addition, multiple
approaches have been used to label and monitor the
dynamics of signalling endosomes: radioactive and/or
fluorescent neurotrophins, antibodies binding the
receptors, toxin fragments and viruses that share the
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same transport route of the neurotrophic factors, to
mention a few. Although these different scenarios are
likely to contribute to the different results accumulat-
ing in the literature, the studies discussed in this review
reveal an intrinsic heterogeneity in the organelles car-
rying neurotrophic signals along the axon. Whether
these organelles are separated compartments with
specific cellular destinations and functions, or whether
they are just different maturation stages of a highly
dynamic and flexible network of intracellular mem-
brane-bound vesicles remain to be addressed.
Altogether, we believe that the available data tend
to disregard the idea of signalling endosomes as an
entirely new class of organelles with distinctive molecu-
lar signatures. Rather, they indicate that trafficking of
neurotrophin receptors exploits multiple routes to
ensure not only efficient and flexible communication
between distal portions of axons and the cell body,
but also a precise regulation of the spatiotemporal
dynamics and compartmentalisation of signalling cas-
cades. In this regard, one of the biggest challenges is
to explain the diversity of destinations of the retro-
grade signalling endosomes after arrival to the soma.
The implementation of new tools for live imaging of
axonal transport in intact tissue [164], as well as the
possibility of purifying and performing quantitative
proteomics of subpopulations of retrograde carriers,
shall be critical to reveal the differences in cargoes,
adaptors, and signalling molecules that characterise
different functional subpools, and to resolve the mech-
anisms of their assembly and disposal.
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